CURIS, INC. 25,652,174 Shares of Common Stock (par value $0.01 per share) Underwriting AgreementUnderwriting Agreement • December 10th, 2020 • Curis Inc • Biological products, (no disgnostic substances) • New York
Curis, Inc., a Delaware corporation (the “Company”), proposes to issue and sell, pursuant to the terms of this Underwriting Agreement (the “Agreement”) to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 25,652,174 shares (the “Shares”) of its common stock, par value $0.01 per share (the “Common Stock”). The 25,652,174 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 3,847,826 Shares pursuant to such option are collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on
